A citation-based method for searching scientific literature

M C van Maaren, M Lagendijk, M M A Tilanus-Linthorst, L de Munck, R M Pijnappel, M K Schmidt, J Wesseling, L B Koppert, S Siesling. Eur J Cancer 2018
Times Cited: 8







List of co-cited articles
48 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Breast-conserving treatment with or without radiotherapy in ductal carcinoma In Situ: 15-year recurrence rates and outcome after a recurrence, from the EORTC 10853 randomized phase III trial.
Mila Donker, Saskia Litière, Gustavo Werutsky, Jean-Pierre Julien, Ian S Fentiman, Roberto Agresti, Philippe Rouanet, Christine Tunon de Lara, Harry Bartelink, Nicole Duez,[...]. J Clin Oncol 2013
212
62

Breast Cancer Mortality After a Diagnosis of Ductal Carcinoma In Situ.
Steven A Narod, Javaid Iqbal, Vasily Giannakeas, Victoria Sopik, Ping Sun. JAMA Oncol 2015
333
50

Management and 5-year outcomes in 9938 women with screen-detected ductal carcinoma in situ: the UK Sloane Project.
Alastair M Thompson, Karen Clements, Shan Cheung, Sarah E Pinder, Gill Lawrence, Elinor Sawyer, Olive Kearins, Graham R Ball, Ian Tomlinson, Andrew Hanby,[...]. Eur J Cancer 2018
35
50

Addressing overtreatment of screen detected DCIS; the LORIS trial.
Adele Francis, Jeremy Thomas, Lesley Fallowfield, Matthew Wallis, John M S Bartlett, Cassandra Brookes, Tracy Roberts, Sarah Pirrie, Claire Gaunt, Jennie Young,[...]. Eur J Cancer 2015
200
50

Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast.
C Correa, P McGale, C Taylor, Y Wang, M Clarke, C Davies, R Peto, N Bijker, L Solin, S Darby. J Natl Cancer Inst Monogr 2010
394
50

Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS.
Irene L Wapnir, James J Dignam, Bernard Fisher, Eleftherios P Mamounas, Stewart J Anderson, Thomas B Julian, Stephanie R Land, Richard G Margolese, Sandra M Swain, Joseph P Costantino,[...]. J Natl Cancer Inst 2011
449
50

Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trial.
Jack Cuzick, Ivana Sestak, Sarah E Pinder, Ian O Ellis, Sharon Forsyth, Nigel J Bundred, John F Forbes, Hugh Bishop, Ian S Fentiman, William D George. Lancet Oncol 2011
329
50

Cause-specific Mortality in a Population-based Cohort of 9799 Women Treated for Ductal Carcinoma In Situ.
Lotte E Elshof, Marjanka K Schmidt, Emiel J Th Rutgers, Flora E van Leeuwen, Jelle Wesseling, Michael Schaapveld. Ann Surg 2018
36
50

Significant inter- and intra-laboratory variation in grading of ductal carcinoma in situ of the breast: a nationwide study of 4901 patients in the Netherlands.
Carmen van Dooijeweert, Paul J van Diest, Stefan M Willems, Chantal C H J Kuijpers, Lucy I H Overbeek, Ivette A G Deckers. Breast Cancer Res Treat 2019
20
50

Breast cancer precursors revisited: molecular features and progression pathways.
Maria A Lopez-Garcia, Felipe C Geyer, Magali Lacroix-Triki, Caterina Marchió, Jorge S Reis-Filho. Histopathology 2010
191
37

Effect of radiotherapy after breast-conserving surgery for ductal carcinoma in situ: 20 years follow-up in the randomized SweDCIS Trial.
Fredrik Wärnberg, Hans Garmo, Stefan Emdin, Veronica Hedberg, Linda Adwall, Kerstin Sandelin, Anita Ringberg, Per Karlsson, Lars-Gunnar Arnesson, Harald Anderson,[...]. J Clin Oncol 2014
120
37

Ductal carcinoma in situ at core-needle biopsy: meta-analysis of underestimation and predictors of invasive breast cancer.
Meagan E Brennan, Robin M Turner, Stefano Ciatto, M Luke Marinovich, James R French, Petra Macaskill, Nehmat Houssami. Radiology 2011
227
37

The diagnostic challenge of low-grade ductal carcinoma in situ.
Tracy Onega, Donald L Weaver, Paul D Frederick, Kimberly H Allison, Anna N A Tosteson, Patricia A Carney, Berta M Geller, Gary M Longton, Heidi D Nelson, Natalia V Oster,[...]. Eur J Cancer 2017
22
37

Concordance between vacuum assisted biopsy and postoperative histology: implications for the proposed Low Risk DCIS Trial (LORIS).
S Soumian, E T Verghese, M Booth, N Sharma, S Chaudhri, S Bradley, S Umranikar, R A Millican-Slater, A M Hanby, A Francis. Eur J Surg Oncol 2013
33
37

Risk factors for the development of invasive cancer in unresected ductal carcinoma in situ.
Anthony J Maxwell, Karen Clements, Bridget Hilton, David J Dodwell, Andrew Evans, Olive Kearins, Sarah E Pinder, Jeremy Thomas, Matthew G Wallis, Alastair M Thompson. Eur J Surg Oncol 2018
43
37

Feasibility of a prospective, randomised, open-label, international multicentre, phase III, non-inferiority trial to assess the safety of active surveillance for low risk ductal carcinoma in situ - The LORD study.
Lotte E Elshof, Konstantinos Tryfonidis, Leen Slaets, A Elise van Leeuwen-Stok, Victoria P Skinner, Nicolas Dif, Ruud M Pijnappel, Nina Bijker, Emiel J Th Rutgers, Jelle Wesseling. Eur J Cancer 2015
192
37

Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes.
Beth A Virnig, Todd M Tuttle, Tatyana Shamliyan, Robert L Kane. J Natl Cancer Inst 2010
376
25

Survival Benefit of Breast Surgery for Low-Grade Ductal Carcinoma In Situ: A Population-Based Cohort Study.
Yasuaki Sagara, Melissa Anne Mallory, Stephanie Wong, Fatih Aydogan, Stephen DeSantis, William T Barry, Mehra Golshan. JAMA Surg 2015
109
25

Ductal carcinoma in situ of the breast: influence of age on diagnostic, therapeutic, and prognostic features. Retrospective study of 812 patients.
Christine Tunon-de-Lara, Gwenaëlle André, Gaétan Macgrogan, Jean-Marie Dilhuydy, Jean-Emmanuel Bussières, Marc Debled, Louis Mauriac, Véronique Brouste, Isabelle de Mascarel, Antoine Avril. Ann Surg Oncol 2011
30
25

Confusion Over Differences in Registration and Randomization Criteria for the LORIS (Low-Risk DCIS) Trial.
Daniel Rea, Adele Francis, Matthew Wallis, Jeremy Thomas, John Bartlett, Sarah Bowden, David Dodwell, Lesley Fallowfield, Claire Gaunt, Andrew Hanby,[...]. Ann Surg Oncol 2017
5
40

Finding the balance between over- and under-treatment of ductal carcinoma in situ (DCIS).
Emma J Groen, Lotte E Elshof, Lindy L Visser, Emiel J Th Rutgers, Hillegonda A O Winter-Warnars, Esther H Lips, Jelle Wesseling. Breast 2017
77
25

Interobserver reproducibility of the Lagios nuclear grading system for ductal carcinoma in situ.
N Sneige, M D Lagios, R Schwarting, W Colburn, E Atkinson, D Weber, A Sahin, B Kemp, A Hoque, S Risin,[...]. Hum Pathol 1999
50
25

Current trials to reduce surgical intervention in ductal carcinoma in situ of the breast: Critical review.
M Toss, I Miligy, A M Thompson, H Khout, A R Green, I O Ellis, E A Rakha. Breast 2017
21
25

Extent of ductal carcinoma in situ according to breast cancer subtypes: a population-based cohort study.
Shusma C Doebar, Esther C van den Broek, Linetta B Koppert, Agnes Jager, Margreet H A Baaijens, Inge-Marie A M Obdeijn, Carolien H M van Deurzen. Breast Cancer Res Treat 2016
31
25

Dichotomous histopathological assessment of ductal carcinoma in situ of the breast results in substantial interobserver concordance.
Mieke Van Bockstal, Marcella Baldewijns, Cécile Colpaert, Hélène Dano, Giuseppe Floris, Christine Galant, Kathleen Lambein, Dieter Peeters, Sofie Van Renterghem, Anne-Sophie Van Rompuy,[...]. Histopathology 2018
19
25


The COMET (Comparison of Operative versus Monitoring and Endocrine Therapy) trial: a phase III randomised controlled clinical trial for low-risk ductal carcinoma in situ (DCIS).
E Shelley Hwang, Terry Hyslop, Thomas Lynch, Elizabeth Frank, Donna Pinto, Desiree Basila, Deborah Collyar, Antonia Bennett, Celia Kaplan, Shoshana Rosenberg,[...]. BMJ Open 2019
104
25

The prevalence and clinical relevance of tumor-infiltrating lymphocytes (TILs) in ductal carcinoma in situ of the breast.
G Pruneri, M Lazzeroni, V Bagnardi, G B Tiburzio, N Rotmensz, A DeCensi, A Guerrieri-Gonzaga, A Vingiani, G Curigliano, S Zurrida,[...]. Ann Oncol 2017
54
25

Do LORIS Trial Eligibility Criteria Identify a Ductal Carcinoma In Situ Patient Population at Low Risk of Upgrade to Invasive Carcinoma?
Melissa Pilewskie, Michelle Stempel, Hope Rosenfeld, Anne Eaton, Kimberly J Van Zee, Monica Morrow. Ann Surg Oncol 2016
54
25

Refined estimates of local recurrence risks by DCIS score adjusting for clinicopathological features: a combined analysis of ECOG-ACRIN E5194 and Ontario DCIS cohort studies.
E Rakovitch, R Gray, F L Baehner, R Sutradhar, M Crager, S Gu, S Nofech-Mozes, S S Badve, W Hanna, L L Hughes,[...]. Breast Cancer Res Treat 2018
28
25

Stromal characteristics are adequate prognosticators for recurrence risk in ductal carcinoma in situ of the breast.
Mieke Van Bockstal, Kathleen Lambein, Ann Smeets, Laurence Slembrouck, Patrick Neven, Ines Nevelsteen, Caroline Weltens, Erik Van Limbergen, Marie-Rose Christiaens, Chantal Van Ongeval,[...]. Eur J Surg Oncol 2019
10
25

Clinical risk score to predict likelihood of recurrence after ductal carcinoma in situ treated with breast-conserving surgery.
Rinaa S Punglia, Wei Jiang, Stuart R Lipsitz, Melissa E Hughes, Stuart J Schnitt, Michael J Hassett, Larissa Nekhlyudov, Ninah Achacoso, Stephen Edge, Sara H Javid,[...]. Breast Cancer Res Treat 2018
11
25

Classification of ductal carcinoma in situ by gene expression profiling.
Juliane Hannemann, Arno Velds, Johannes B G Halfwerk, Bas Kreike, Johannes L Peterse, Marc J van de Vijver. Breast Cancer Res 2006
117
25

Nomogram for predicting the risk of local recurrence after breast-conserving surgery for ductal carcinoma in situ.
Udo Rudloff, Lindsay M Jacks, Jessica I Goldberg, Christine A Wynveen, Edi Brogi, Sujata Patil, Kimberly J Van Zee. J Clin Oncol 2010
204
25

Ductal carcinoma in situ - update on risk assessment and management.
Jia-Min B Pang, Kylie L Gorringe, Stephen B Fox. Histopathology 2016
29
25

Surgical Upstaging Rates for Vacuum Assisted Biopsy Proven DCIS: Implications for Active Surveillance Trials.
Lars J Grimm, Marc D Ryser, Ann H Partridge, Alastair M Thompson, Jeremy S Thomas, Jelle Wesseling, E Shelley Hwang. Ann Surg Oncol 2017
48
25


Carcinoma in situ of the breast in New South Wales, Australia: Current status and trends over the last 40 year.
Gemma Jacklyn, Stephen Morrell, Kevin McGeechan, Nehmat Houssami, Les Irwig, Nirmala Pathmanathan, Alexandra Barratt. Breast 2018
8
25

Review of the national external quality assessment (EQA) scheme for breast pathology in the UK.
Emad A Rakha, Rachel L Bennett, Derek Coleman, Sarah E Pinder, Ian O Ellis. J Clin Pathol 2017
27
25

Current approach and future perspective for ductal carcinoma in situ of the breast.
Chizuko Kanbayashi, Hiroji Iwata. Jpn J Clin Oncol 2017
37
25

Molecular Evaluation of Breast Ductal Carcinoma in Situ with Oncotype DX DCIS.
Sharon Nofech-Mozes, Wedad Hanna, Eileen Rakovitch. Am J Pathol 2019
16
25

Protocol for the examination of specimens from patients with ductal carcinoma in situ of the breast.
Susan C Lester, Shikha Bose, Yunn-Yi Chen, James L Connolly, Monica E de Baca, Patrick L Fitzgibbons, Daniel F Hayes, Celina Kleer, Frances P O'Malley, David L Page,[...]. Arch Pathol Lab Med 2009
99
25

Cancer statistics: Breast cancer in situ.
Elizabeth M Ward, Carol E DeSantis, Chun Chieh Lin, Joan L Kramer, Ahmedin Jemal, Betsy Kohler, Otis W Brawley, Ted Gansler. CA Cancer J Clin 2015
141
25

Breast-conserving therapy for primary Ductal Carcinoma in Situ in The Netherlands: A multi-center study and population-based analysis.
Jan J Jobsen, Luc J E E Scheijmans, Wilma G J M Smit, Marika C Stenfert Kroese, Henk Struikmans, Job van der Palen. Breast 2018
7
28



The distribution of ductal carcinoma in situ (DCIS) grade in 4232 women and its impact on overdiagnosis in breast cancer screening.
P A van Luijt, E A M Heijnsdijk, J Fracheboud, L I H Overbeek, M J M Broeders, J Wesseling, G J den Heeten, H J de Koning. Breast Cancer Res 2016
41
25


Management of elderly patients with breast cancer: updated recommendations of the International Society of Geriatric Oncology (SIOG) and European Society of Breast Cancer Specialists (EUSOMA).
Laura Biganzoli, Hans Wildiers, Catherine Oakman, Lorenza Marotti, Sibylle Loibl, Ian Kunkler, Malcolm Reed, Stefano Ciatto, Adri C Voogd, Etienne Brain,[...]. Lancet Oncol 2012
368
12



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.